trial

Clinical and Genetic Influencing Factors on Clozapine Pharmacokinetics

NCTId NCT04240496
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 51 (actual)
Sponsored by University of Monastir
Primary completion 2019-12-14
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
51 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2019-10-17
Primary completion
2019-12-14
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Clozapine

Sponsors

University of MonastirLead Sponsor

Sites

1 total
Monastir, Tunisia

Facts & assertions

4 sourced
Enrollment
51
Phase
NA
Primary Completion Date
2019-12-14
Status
COMPLETED
relationships
The graph out of here
drug
Clozapine
drug
lead_sponsor
University of Monastir
company
indication
CYP2C19 Polymorphism
indication
Clozapine
indication
Schizophrenia
indication